Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Keratosis, Actinic 12Warts 11Breast Neoplasms 11Uterine Cervical Dysplasia 7Retinoblastoma 6Prostatic Neoplasms 6Peripheral Nervous System Diseases 6Pain 6Neoplasm Metastasis 6Lung Neoplasms 6Neoplasms 5Stomatitis 4Pancreatic Neoplasms 3Mucositis 3Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Stomach Neoplasms 2Multiple Myeloma 2Mesothelioma 2Melanoma 2Keratosis 2Condylomata Acuminata 2Carcinoma, Ductal, Breast 2Carcinoma, Basal Cell 2Bone Neoplasms 2Barrett Esophagus 2Adenocarcinoma Of Esophagus 2Wilms Tumor 1

Interventions

aldesleukin 42Sunitinib 39Cyclophosphamide 30Nivolumab 27Everolimus 27pembrolizumab 26Interferon-alpha 25Bevacizumab 22Sorafenib 21Interleukin-2 20fludarabine phosphate 19Filgrastim 18Ipilimumab 17Radiotherapy 16Axitinib 16Peripheral Blood Stem Cell Transplantation 15Gemcitabine 15cabozantinib 14fludarabine 11Radiosurgery 11Doxorubicin 11Carboplatin 11temsirolimus 10Etoposide 9Chemotherapy, Adjuvant 9sargramostim 8belzutifan 8atezolizumab 8Fluorouracil 8pazopanib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Kidney Neoplasms × Cryotherapy × Clear all
NCT03540199 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2 Withdrawn
Genitourinary

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡